Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Ampersand Buys Calloway Labs, Enters Pain Management Market

Acquisition gives Ampersand a stake in lab test niche that has had Medicare/Medicaid compliance issues

URINE DRUG TESTING for pain management may be a challenging business for clinical labs given that compliance officers in the states and in the federal government have successfully pursued lab compliance abuses in this line of business in recent years. Now comes news that private equity firm Ampersand Capital Partners of Wellesley, Massachusetts, is to …

Ampersand Buys Calloway Labs, Enters Pain Management Market Read More »

To access this post, you must purchase The Dark Report.



You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.